Basic Information
| LncRNA/CircRNA Name | SNHG17 |
| Synonyms | NA |
| Region | GRCh38_20:38420588-38435353 |
| Ensemble | ENSG00000196756 |
| Refseq | NR_015366 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | glioma |
| ICD-0-3 | NA |
| Methods | RT-qPCR, Western blot |
| Sample | glioma tissues,cell lines |
| Expression Pattern | up-regulated |
| Function Description | YY1-induced SNHG17 facilitated the glioma progression through targeting miR-506-3p/CTNNB1 axis to activate Wnt/? catenin signaling pathway offered a brand-new prospects to molecular-targeted treatment for glioma. |
| Pubmed ID | 32009853 |
| Year | 2020 |
| Title | Long noncoding RNA SNHG17 induced by?YY1 facilitates the?glioma progression through?targeting miR-506-3p/CTNNB1 axis to?activate Wnt/?-catenin signaling pathway |
External Links
| Links for SNHG17 | GenBank HGNC NONCODE |
| Links for glioma | OMIM COSMIC |